Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Patent watch

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Worldwide sales at risk from patent expiration (2004–2018).

References

  1. EvaluatePharma. World Preview 2018 — Embracing the patent cliff. EvaluatePharma website [online], (2012).

  2. Palmer, E. Top 20 generic molecules worldwide. FiercePharma website [online], (2012).

  3. IMS Institute for Healthcare Informatics. The global use of medicines: outlook through 2016. IMS Health website [online], (2012).

  4. Medtrack. Medtrack Patent Report — 2013 expiring patents. (2011).

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Harrison, C. Patent watch. Nat Rev Drug Discov 12, 14–15 (2013). https://doi.org/10.1038/nrd3924

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3924

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing